About Igor Nasonkin, Ph.D.
Form D filings for Phythera Therapeutics in 2024 list Igor Nasonkin, Ph.D. as chief executive officer and director.
Igor Nasonkin, Ph.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Igor Nasonkin, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Igor Nasonkin, Ph.D. works with at each company, as listed on that company's latest Form D.
Phythera Therapeutics Inc. · Form D, May 16, 2024
NT
Ngoc Tran
Executive officer and promoter
CD
Charles Irving, Ph.D.
Executive officer, director and promoter
HD
Hal Sternberg, Ph.D.
Executive officer, director and promoter
JS
Judith Segall
Executive officer, director and promoter
ZN
Zamira Nasonkin
Promoter